Offstream
news

Georgia receives 43,200 doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.
2021-07-10

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

Yemen begins their COVID-19 vaccination campaign using the vaccine produced by AstraZeneca and the University of Oxford.
2021-04-20

The Haiti government rejects an offer from the World Health Organization to receive 756,000 doses of the vaccine produced by AstraZeneca.
2021-04-6

Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.
2021-03-22

The Therapeutic Goods Administration approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca for people over 18 years of age in Australia.
2021-02-16

South Africa approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country.
2021-01-27

Chile's health regulator approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country.
2021-01-27

Brazil begins distribution of the AstraZeneca-Oxford University vaccine.
2021-01-23

India approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca, becoming the third country in the world to do so after the United Kingdom and Argentina.
2021-01-1